Centers for Disease Control and Prevention - ERA

Description

The purpose of this funding is to support etiologic and effectiveness research on driving while polysubstance impaired. Specifically, research is solicited to identify risk and protective factors associated with polysubstance impaired driving and its associated deaths and injuries, or to identify effective interventions to prevent polysubstance impaired driving and its associated deaths and injuries. Polysubstance impaired driving includes driving while impaired by alcohol plus at least one other drug, such as marijuana or opioids.Research Priority #1 is to conduct etiologic research to inform our understanding of the characteristics of and risk and protective factors associated with impaired driving when alcohol plus other drugs (such as marijuana or prescription or illicit opioids) are involved. Research Priority #2 is to conduct effectiveness research to evaluate interventions most effective at preventing driving while impaired by alcohol plus other drugs (such as marijuana or prescription or illicit opioids).

Who can apply

• State governments
• County governments
• City or township governments
• Special district governments
• Independent school districts
• Public and State controlled institutions of higher education
• Native American tribal governments (Federally recognized)
• Public housing authorities / Indian housing authorities
• Native American tribal organizations (other than Federally recognized)
• Nonprofits with 501(c)(3) status (other than higher education)
• Nonprofits without 501(c)(3) status (other than higher education)
• Private institutions of higher education
• For-profit organizations other than small businesses
• Small businesses
• Unrestricted

Contact

Dan Holcomb<br/>DWH6@cdc.gov
DWH6@cdc.gov